Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Caredx Inc
(NQ:
CDNA
)
31.92
+0.38 (+1.20%)
Streaming Delayed Price
Updated: 9:59 AM EDT, Aug 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Caredx Inc
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Earnings Outlook For CareDx
February 27, 2024
Via
Benzinga
CareDx to Report Fourth Quarter and Full Year 2023 Financial Results
February 21, 2024
From
CareDx, Inc.
Via
Business Wire
CareDx Showcases Digital Solutions and Pipeline in Cellular Transplant and Therapy Monitoring at the 2024 Tandem Meetings
February 21, 2024
From
CareDx, Inc.
Via
Business Wire
3 Strong Buy Biotech Stocks to Add to Your February Must-Watch List
February 06, 2024
These biotech stocks offer investors huge potential in the future. Investors may want to consider these equities to enter the industry.
Via
InvestorPlace
CareDx: Q3 Earnings Insights
November 08, 2023
Via
Benzinga
Earnings Outlook For CareDx
November 07, 2023
Via
Benzinga
CareDx Earnings Preview
August 07, 2023
Via
Benzinga
CareDx Issues Statement in Patent Infringement Case
January 26, 2024
From
CareDx, Inc.
Via
Business Wire
Natera Hits A Nearly Two-Year High After Notching A Win In A Patent Battle
January 17, 2024
The company must pay $57 million in damages, but that's far less than expected.
Via
Investor's Business Daily
Topics
Intellectual Property
Exposures
Intellectual Property
CareDx Adds to AlloSure Kidney and HeartCare Utility and Clinical Data at 2024 American Society of Transplant Surgeons Winter Symposium
January 11, 2024
From
CareDx, Inc.
Via
Business Wire
CareDx Reports Preliminary Revenue Results for Fourth Quarter and Full Year 2023
January 09, 2024
From
CareDx, Inc.
Via
Business Wire
CareDx Joins Forces with the National Foundation for Transplants to Improve Post-Transplant Medication Adherence
December 19, 2023
From
CareDx, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
November 09, 2023
Via
Benzinga
CareDx Reports Third Quarter 2023 Results
November 08, 2023
From
CareDx, Inc.
Via
Business Wire
CareDx to Report Third Quarter 2023 Financial Results
November 02, 2023
From
CareDx, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
November 02, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
November 01, 2023
Via
Benzinga
CareDx Announces CEO Transition
November 01, 2023
From
CareDx, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Monday's After-Market Session
October 23, 2023
Via
Benzinga
CareDx Presents New Data at the American Society for Histocompatibility and Immunogenetics Annual Meeting
October 17, 2023
From
CareDx, Inc.
Via
Business Wire
CareDx Issues Statement on Supreme Court Decision Regarding Stanford-Licensed Patents
October 03, 2023
From
CareDx, Inc.
Via
Business Wire
CareDx To Present at the 2023 Cantor Global Healthcare Conference
September 19, 2023
From
CareDx, Inc.
Via
Business Wire
CareDx To Present at the H.C. Wainwright 25th Annual Global Investment Conference
August 31, 2023
From
CareDx, Inc.
Via
Business Wire
CareDx Hosts Second Annual MEET Digital Health User Conference to Showcase Latest Innovations to Enhance Transplant Patient Care
August 17, 2023
From
CareDx, Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For August 15, 2023
August 15, 2023
Via
Benzinga
CareDx Comments on Issuance of Proposed LCD for Molecular Testing for Solid Allograft Rejection
August 11, 2023
From
CareDx, Inc.
Via
Business Wire
CareDx Reports Second Quarter 2023 Results
August 08, 2023
From
CareDx, Inc.
Via
Business Wire
CareDx Announces District Court Judge Bars Natera from Falsely Advertising and Overstating the Scientific Performance of its Prospera Transplant Test
August 07, 2023
From
CareDx, Inc.
Via
Business Wire
CareDx to Report Second Quarter 2023 Financial Results
August 03, 2023
From
CareDx, Inc.
Via
Business Wire
Why Exact Sciences Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
August 02, 2023
Gainers WaveDancer, Inc. (NASDAQ: WAVD) shares climbed 86% to $0.5505. Tellenger, a subsidiary of Wavedancer, Inc., won a seven-year U.S. government contract.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.